Sign in

CIK 0001581280 · Large accelerated filer

Twist Bioscience Corp

Sign in to watch
Ticker
TWST
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
462058888
Phone
800-719-0671
Business address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$99,863,292
in 32 filings, $84.3M under 10b5-1 plans

Net −$99,863,292. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-17 Finn Patrick John President and COO Option exercise · Stock Option (right to buy) 10b5-1 −32,300 0
2026-02-17 Finn Patrick John President and COO Option exercise · Stock Option (right to buy) 10b5-1 −18,205 0
2026-02-13 CHESS ROBERT Director Sale −2,184 $48.26 $105K 21,084
2026-02-13 Finn Patrick John President and COO Option exercise 10b5-1 +500 $23.33 $12K 307,288
2026-02-13 Finn Patrick John President and COO Option exercise 10b5-1 +712 $26.66 $19K 308,000
2026-02-13 Finn Patrick John President and COO Sale 10b5-1 −1,750 $50.04 $88K 306,250
2026-02-13 Finn Patrick John President and COO Option exercise · Stock Option (right to buy) 10b5-1 −712 32,300
2026-02-13 Finn Patrick John President and COO Option exercise · Stock Option (right to buy) 10b5-1 −500 18,052
2026-02-12 Finn Patrick John President and COO Option exercise 10b5-1 +1,000 $23.33 $23K 308,788
2026-02-12 Finn Patrick John President and COO Option exercise 10b5-1 +1,500 $26.66 $40K 310,288
2026-02-12 Finn Patrick John President and COO Sale 10b5-1 −3,500 $50.23 $176K 306,788
2026-02-12 Finn Patrick John President and COO Option exercise · Stock Option (right to buy) 10b5-1 −1,500 33,012
2026-02-12 Finn Patrick John President and COO Option exercise · Stock Option (right to buy) 10b5-1 −1,000 18,705
2026-02-12 Laponis Adam Chief Financial Officer Sale 10b5-1 −7,000 $50.00 $350K 130,031

Page 10 of 10 · 194 trades